FDAFDA · Food and drugs·Recall number D-0122-2024
Paroxetine Hydrochloride Tablets USP, RX only, 40 mg, 1000-count bottle, NDC#:60505-0101-4 Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326.
Published December 6, 2023 · Recall initiated: November 1, 2023
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications-Out of specification (OOS) results for the excipient Amadori Glucose adduct of Paroxetine
What to do
Voluntary: Firm initiated · E-Mail
Recall details
- Brand
- PAROXETINE
- Manufacturer
- Apotex Corp.
- Distributor
- Nationwide
- UPC
- 0360505010110
- Lot
- Lot numbers: RV0131, RV2387, RV2389, RW3296, RV2388; Exp. 08/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.